Bottom line
LYFAX vs SHSSX: the short answer
LYFAX (AlphaCentric Life Sciences and Healthcare Fund) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
But SHSSX is far broader, holding 155 positions to 62 for LYFAX, so beyond the top names it adds exposure LYFAX doesn't have.
SHSSX is cheaper at 0.86% vs 1.66% — a difference of $80 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +4.1% for LYFAX.
LYFAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
LYFAX vs SHSSX side by side
| LYFAX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Mutual | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.66% | 0.86% |
| Annual cost per $10k | $166 | $86 |
| 10-yr cost on $10k (prospectus) | $3,039 | $1,061 |
| Max front load | 5.75% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +20.6% | +16.3% |
| 5-yr return (annualized) | +4.1% | +5.9% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +27.5% | — |
| Worst quarter | −11.9% | — |
| Net assets (fund) | $46.6M | $5.9B |
| Number of holdings | 62 | 155 |
| Portfolio turnover | 107% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
6 of LYFAX's top 25 holdings also appear in SHSSX's top 25.
| Holding | LYFAX | SHSSX |
|---|---|---|
| Gilead Sciences Inc | 5.53% | 4.19% |
| Vertex Pharmaceuticals Inc | 5.33% | 2.74% |
| Argenx Se | 3.59% | 1.26% |
| Abbvie Inc | 1.95% | 3.94% |
| Amgen Inc | 1.83% | 3.37% |
| Biogen Inc | 1.80% | 1.21% |
Source: SEC Form N-PORT
LYFAX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between LYFAX and SHSSX?
Which is cheaper, LYFAX or SHSSX?
Should I own both LYFAX and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.